SoFi Hong Kong Blog - US_NVO
A New Opportunity This year saw the rise of powerful new weight loss drugs such as Novo Nordisk’s (NVO) Ozempic and Wegovy. But food companies are seeing an opportunity. These new drugs work by suppressing appetites, which has left many investors bearish on food suppliers as more Americans begin taking these drugs. However, savvy food…閱讀更多
承擔重量 Ozempic和Wegovy可能幫助患者減肥，但它們在經濟上的影響只會越來越大。 根據行業分析師估計，到2030年，大約有4800萬美國人將因為這些治療而一共減掉數百萬磅的體重。這些預測對患…閱讀更多